Form 4 for CLPT ClearPoint Neuro, Inc.

Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0000950170-25-074448 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-05-19	2025-05-16	CLPT	Klein Matthew B.	Dir	M - OptEx	—	+21.1K	50.5K	+72%	—
D	2025-05-19	2025-05-16	CLPT	Klein Matthew B.	Dir	M - OptEx	—	-21.1K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-05-16	M	A	21,093	—	50,518	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
2	Derivative	Restricted Stock Units	2025-05-16	M	D	21,093	—	0	D	— · — to —	21,093 Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.